The level of protection against rotavirus shedding in mice following immunization with a chimeric VP6 protein is dependent on the route and the coadministered adjuvant-Reference-Cited by-同舟云学术

The level of protection against rotavirus shedding in mice following immunization with a chimeric VP6 protein is dependent on the route and the coadministered adjuvant

Published:2002-03 Issue:13-14 Volume:20 Page:1733-1740
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Choi Anthony H.,McNeal Monica M.,Flint Jason A.,Basu Mitali,Lycke Nils Y.,Clements John D.,Bean Judy A.,Davis Heather L.,McCluskie Michael J.,VanCott John L.,Ward Richard L.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference32 articles.

1. World Health Organization. Rotavirus vaccines. Weekly epidemiological record. 1999;74:33–40.

2. Rotavirus intussusception investigation team: intussusception among infants given an oral rotavirus vaccine;Murphy;N. Engl. J. Med.,2001

3. Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein;Choi;J. Virol.,1999

4. Functional Mapping of protective domains and epitopes in the rotavirus VP6 protein;Choi;J. Virol.,2000

5. Comparison of the rotavirus gene 6 from different species by sequence analysis and localization of subgroup-specific epitopes using site-directed mutagenesis;Tang;Virology,1997

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rotavirus VP6: involvement in immunogenicity, adjuvant activity, and use as a vector for heterologous peptides, drug delivery, and production of nano-biomaterials;Archives of Virology;2022-03-15

2. Co-administration of rotavirus nanospheres VP6 and NSP4 proteins enhanced the anti-NSP4 humoral responses in immunized mice;Microbial Pathogenesis;2022-02

3. Parenteral, non-live rotavirus vaccine: recent history and future perspective;Clinical and Experimental Vaccine Research;2021

4. Polyphosphazene immunoadjuvants: Historical perspective and recent advances;Journal of Controlled Release;2021-01

5. Xyloglucan based mucosal nanovaccine for immunological protection against brucellosis developed by supercritical fluid technology;International Journal of Pharmaceutics: X;2020-12